Stockreport

The experimental drug transforming weight loss, retatrutide [USA TODAY]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF AI Overview Full Summary Retatrutide is an experimental injectable drug from Eli?Lilly that acts as a triple-agonist on GLP-1, GIP and glucagon receptors, showing gre [Read more]